WAVE Life Sciences (WVE) Tops Q1 EPS by 19c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $38.25 million versus the consensus estimate of $8.34 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• USA Compression Partners LP (USAC) PT Raised to $31 at RBC Capital
• GoPro to merge with Starman Optical in $285M recapitalization deal